Display search results for ** instead (4 products)

4 Item(s)

02 Feb 2017  |  Europe

European Next-generation Sequencing Services Market, Forecast to 2023

Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...

USD 4,950.00

USD 3,712.50 save 25 %

29 Mar 2017  |  Europe

Biosimilars Market, Europe, Forecast to 2025

A Growing Number of Incentive Policies to Propel Growth in the Next 5–7 Years, with Oncology as the Fastest Adopter

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

USD 4,950.00

USD 3,712.50 save 25 %

31 May 2017  |  Europe

Growth Opportunities in the European Next-generation Sequencing Informatics Market, Forecast to 2021

Big-data-driven Clinical Interpretation in Novel Areas is Set to Drive Market Growth

The cost of genomic sequencing has significantly declined in the recent past with the utilization of high-throughput sequencers creating opportunities for Next-generation Sequencing (NGS) informatics to develop genetic insights from the growing volume of sequencing data. As NGS technologies mature and the market stakeholders develop clarity on indu...

USD 4,950.00

USD 3,712.50 save 25 %

30 Jun 2017  |  Europe

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

Data-driven Solutions and Co-development are Key Growth Drivers

The Western European Oncology Diagnostics Market, Forecast to 2021 study presents an overview of the oncology diagnostics market landscape in the Western European countries, with a focus on EU 5. The analysis provides forecasts for the EU 5 markets, segmented by types of cancer, which include breast cancer, ovarian cancer, cervical cancer, prostate...

USD 4,950.00

USD 3,712.50 save 25 %

4 Item(s)